Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_assertion description "[In this pilot study, we utilized a retroviral vector expressing methylguanine DNA methyltransferase (MGMT) to transduce hematopoietic progenitors, which were subsequently used in the setting of alkylator therapy (procarbazine, CCNU, vincristine (PCV)) for poor prognosis brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_assertion evidence source_evidence_literature NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_assertion SIO_000772 16645619 NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_assertion wasDerivedFrom befree-20140225 NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_assertion wasGeneratedBy ECO_0000203 NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP330029.RAD6dFAAJbeVUnMWjT2phbuts_F84gq50X6pL5Bh_g7zg130_provenance.